CGTX earnings: next report 2026-08-06, real EPS beat/miss history, analyst consensus Buy, P/E -3.67. Updated 2026-07-23.
Cognition Therapeutics (CGTX) Research Hub
Cognition Therapeutics (CGTX) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 0.9828 USD (-0.73%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -3.67, market cap 0.07B. This hub links to the full technical, earnings and options research available for CGTX.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 0.9828 USD (-0.73%) |
| 52-week range | 0.88 USD – 1.76 USD |
| Trend regime | Range |
| 14-day RSI | 36.5 (Bearish) |
| Trailing P/E | -3.67 |
| Market cap | 0.07B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-06 |
Available research for CGTX
Covered Call on CGTX: how it works, illustrative setup around the real 0.9828 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on CGTX: how it works, illustrative setup around the real 0.9828 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on CGTX: how it works, illustrative setup around the real 0.9828 USD price, max profit/loss, breakeven and when to use it. Educational.
CGTX technical analysis: range, last 0.9828 USD, RSI 36.5, 52w range 0.88 USD–1.76 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is CGTX in?
Cognition Therapeutics (CGTX) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is CGTX in an uptrend or downtrend?
As of 2026-09-11, CGTX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is CGTX's trailing P/E ratio?
CGTX's trailing P/E is -3.67, with a market cap of 0.07B. See the earnings research page for full valuation detail.
When does CGTX next report earnings?
CGTX is next scheduled to report earnings on 2026-08-06, with a consensus EPS estimate of -0.06 USD.